Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Financings in Brief: International Remote Imaging Systems

This article was originally published in The Gray Sheet

Executive Summary

International Remote Imaging Systems: Corange International Limited has exercised a warrant to purchase 248,571 IRIS common shares at an aggregate price of $932,141 in cash. The deal increases Corange's stake in IRIS from 4.1% to 8.3% of outstanding shares. Corange obtained the warrant as part of an April 1994 $1.2 mil. investment in LDA Systems, which at the time had a joint development agreement with IRIS for the White Iris automated high-speed instrument for analyzing white blood cell composition. In April 1995, IRIS exercised an option to acquire all outstanding callable LDA common stock. Corange, which acquired its 4.1% share in IRIS by exchanging its LDA stock during the acquisition, holds an additional warrant to purchase 250,000 shares of IRIS stock for $7.375 per share...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT004554

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel